CClinicalTrials.gg
CompletedNCT03457350Updated May 3, 2022

Office Hysteroscopy Versus Cervical Probing for Cervical Stenosis

An interventional study of cervical negotiation in Hysteroscopy, sponsored by Woman's Health University Hospital, Egypt. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-05-03.

Sponsored by Woman's Health University Hospital, Egypt · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
Female
01

Study summary

This study aims to estimate if performing a small caliber office hysteroscopic cervical negotiation would succeed to bypass tight markedly stenotic cervix in comparison to blind cervical probing done under general anesthesia. Moreover, the investigators test the impact of drawing a detailed diagram after this procedure on the success of ET in participants with failed mock or actual trials of embryo transfer (ET).

Read the detailed description

It comprises 122 nulliprous women with failed cervical sounding on vaginal examination in the office. Participants were divided into 2 groups. Group A comprised 64 cases subjected to small-caliber office hysteroscopic cervical negotiation while 58 cases were subjected to cervical probing under general anesthesia. Main outcome measures included success to bypass primary cervical stenosis and complication rate

02

Conditions studied

  • Hysteroscopy

Keywords

  • hysteroscopy
  • cervical stenosis
  • probing
03

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Nulliprous women.
  • Failed cervical sounding on vaginal examination in the office.

Exclusion criteria

Exclusion Criteria:

  • Previous operation on the cervix.
  • Use of any medication to prime the cervix (primary).
  • Multiparity: weather delivered vaginally or by cesarean sectrion
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
128 participants (actual)

Study arms

  • Experimental
    office hysteroscopy

    Office hysteroscopy 30 degrees 2.6 mm telescope with an outer sheath of 3.2 mm (Storz Co., Tutlingen, Germany). Hysteroscopy is performed as usual by proper examination of the vagina and the ectocervix for any abnormality followed by introduction of the hysteroscope into the cervical canal. At this step, the hysteroscopist waits for a while until the distending fluid forms a micro-cavity. At this point, the telescope is advanced with necessary rotatory movements of the 30 degrees telescope guided by the vision of the dark spot which is the internal os. If it is reached, again waiting for some time to allow fluid distension of the internal os area.

    Procedure: cervical negotiation

  • Experimental
    blind cervical probing

    Cervical probing is started with a 2 mm probe after grasping the cervix with a multi-tooth tenaculum put anteriorly or posteriorly according to prior transabdominal or transvaginal sonographic examination of the cervical canal. If the probe succeedes to bypass the internal os, a higher caliber probe is used. Thereafter, a uterine sound (4mm = 1.33 Fr) is introduced into the endometrial cavity. Lastly, gentle cervical dilatation up to Hegar's 8 is performed as usual with classic leaving each dilator for 30 seconds inside the internal os. If probes couldn't bypass the internal os, the procedure is considered failed. If the probe enters a cavity other than endometrial cavity, a false passage is considered.

    Procedure: cervical negotiation

Interventions

  • Procedurecervical negotiation

    trial to bypass severe cervical stenosis

05

What researchers measure

Primary outcomes

  1. How many cases of access to the endometrial cavity

    overcoming cervical stenosis

    Time frame: 20 minutes

Secondary outcomes

  1. complication rate

    how many cases with perforation or false passage

    Time frame: 20 minutes

06

Study locations

1 site
  • Woman's Health University Hospital
    Assiut, 71111, Egypt
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03457350
Lead sponsor
Woman's Health University Hospital, Egypt
Responsible party
Professor Atef Darwish (Professor Dr Atef Darwish MD PhD, Woman's Health University Hospital, Egypt) — Principal investigator
First posted
Mar 7, 2018
Start date
Jan 1, 2012
Primary completion
Feb 2018
Completion
Feb 2018
Last update
May 3, 2022

Study contacts

Atef Darwish
principal investigator · Woman's |Health University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion